REduction in the incidence of GEstational DIAbetes mellitus (GDM) with MEDDiet/Lifestyle
- Conditions
- Gestational Diabetes MellitusDiabetes mellitus arising in pregnancyNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN84389045
- Lead Sponsor
- The Health Research Institute at the Hospital Clinico San Carlos (Spain)
- Brief Summary
1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/29049303 (added 24/01/2019) 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30554220 (added 31/03/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 697
1. Women aged over 18
2. With normal fasting glucose values (< 92 mg/dl) in the 1st gestational assessment (8-12 GWs)
3. Who sign the informed consent
Added 30/08/2017: 4. Having attended GDM screening at 24-28 gestational weeks
Added 26/01/2018: 5. Who did not develop GDM
1. Women with fasting glucose levels >92 mg/dl in the 1st gestational assessment (8-12 GWs)
2. Multiple pregnancy
3. Nut allergy or any other medical condition
4. Ongoing medication
5. Significant disability that would prevent the participant from complying with trial consent, treatment and follow-up procedures or potentially jeopardize her medical care
Added 26/01/2018: 6. GDM diagnosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.